The Desmopressin Shortage: Where Things Stand in 2026

If you rely on Desmopressin — whether as DDAVP nasal spray, generic tablets, Nocdurna, Stimate, or Noctiva — you've likely dealt with pharmacy stock issues over the past few years. The Desmopressin shortage has been one of the more frustrating supply chain problems in recent memory, especially for patients with conditions like diabetes insipidus who literally can't go without this medication.

Here's what you need to know about Desmopressin availability in 2026.

Is Desmopressin Still in Shortage?

The answer depends on which formulation you need:

• Generic oral tablets (0.1 mg, 0.2 mg): Generally available at most pharmacies. This is the most stable part of the supply chain.
• DDAVP nasal spray (10 mcg/spray): This formulation has been the most affected. A significant shortage began in early 2025, with the branded DDAVP 10 mcg nasal spray going out of stock. Resupply was initially expected by September 2025, but availability has remained inconsistent into 2026, particularly for the branded version.
• Stimate nasal spray (150 mcg/spray): Used for bleeding disorders, this high-concentration spray has experienced periodic shortages. Availability varies by region.
• Nocdurna sublingual tablets: Generally available but may require prior authorization from insurance.
• Noctiva nasal spray: Limited availability; this product has had ongoing distribution challenges.
• Desmopressin injection (4 mcg/mL): Hospital supply has been more stable, but periodic shortages have occurred.

Why Has Desmopressin Been So Hard to Find?

Several factors have converged to create this extended shortage:

Manufacturing Concentration

Ferring Pharmaceuticals is the primary manufacturer of most branded Desmopressin products (DDAVP, Stimate, Nocdurna). When a single manufacturer dominates production of a medication, any production delay creates a ripple effect across the entire market. Generic manufacturers have helped with oral tablet supply, but specialty formulations like nasal sprays have fewer producers.

Peptide Manufacturing Complexity

Desmopressin is a synthetic peptide — not a simple small-molecule drug. Manufacturing peptides requires specialized equipment, quality controls, and raw materials. Scaling up production in response to shortages takes time, often 12-18 months.

Regulatory Requirements

Any changes to manufacturing processes require FDA approval, which adds time to resolving supply issues. Companies can't simply switch to a new facility or production line without extensive validation.

Increased Patient Population

The approval of Nocdurna (2018) and Noctiva (2017) for nocturia in adults brought many more patients into the Desmopressin market. This increased demand wasn't always matched by production capacity increases.

What Does Desmopressin Cost in 2026?

Cost varies significantly by formulation:

• Generic oral tablets (30-day supply): $20-$55 with discount coupons (GoodRx, SingleCare, etc.)
• DDAVP nasal spray (branded): $200-$400 without insurance
• Stimate nasal spray: $3,000-$5,000 without insurance (specialty product for bleeding disorders)
• Nocdurna sublingual tablets: $400-$500 for 30 tablets without insurance
• Generic nasal spray: $50-$150 with coupons when available

For more details on saving money, see our complete guide on how to save money on Desmopressin in 2026.

Are There New Options for Desmopressin Patients?

A few developments may help patients in 2026:

• Additional generic manufacturers: More companies have entered the generic Desmopressin oral tablet market, helping stabilize tablet supply and reduce prices.
• Compounding pharmacy options: During the 2023 shortage, FDA-registered 503B compounding pharmacies (like STAQ Pharma) began producing Desmopressin nasal spray. This option may still be available through your doctor.
• Alternative formulation switching: Doctors are increasingly comfortable switching patients between formulations when one is unavailable. If you've only tried one form, ask about others.

How to Find Desmopressin in Stock Right Now

Here are the most effective strategies:

1. Use Medfinder — Search pharmacy inventory near you to find which locations have Desmopressin in stock today.
2. Call independent pharmacies — They often have stock that chain pharmacies don't.
3. Ask about compounding — If commercial products are unavailable, ask your doctor about a compounding pharmacy prescription.
4. Try mail-order pharmacies — Larger inventory and 90-day supply options.
5. Refill early — Don't wait until your last dose. Most insurance allows refills 7-10 days before your supply runs out.

For a more detailed guide, read our article on how to find Desmopressin in stock near you.

Final Thoughts

The Desmopressin shortage has been a long and difficult experience for patients, particularly those with diabetes insipidus who have no safe alternative. The good news is that generic oral tablets remain widely available and affordable, and tools like Medfinder make it easier than ever to locate the specific formulation you need.

Stay proactive with your refills, keep an open line of communication with your doctor about backup plans, and don't hesitate to explore all your options. If you're considering alternatives, check out our guide to alternatives to Desmopressin.